ARK 每周股评 – 7/17/2021

我们每周都会与投资者分享我们策略中一周内一天内升值或下跌超过15%的股票的周评。我们希望您觉得这篇评论有用。

We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.

Recursion Pharmaceuticals (RXRX)
-19%Recursion Pharmaceuticals (RXRX), a pioneering drug-discovery company at the interface between artificial intelligence and biology, traded down approximately 19% on Wednesday during a broad market selloff that hit biotech particularly hard. As one of its IPO investors, we feel confident that Recursion’s drug-discovery and optimization engine, Recursion OS, is second to none in the therapeutics industry. Recursion’s platform is a low-latency feedback loop that incorporates wet-lab cell experiments, novel computer vision techniques (phenomics), and powerful AI systems to inference therapeutic candidates in the chemical space.

注: Recursion Pharmaceuticals (RXRX) 是一家位于人工智能和生物学之间的先锋药物发现公司,在周三大盘下跌期间,交易量下降了约19%,这对生物技术的打击尤为严重。作为其IPO投资者之一,我们确信Recursion的药物发现和优化引擎Recursion OS在治疗行业是首屈一指的。Recursion的平台是一个低延迟的反馈回路,它结合了湿式实验室细胞实验、新颖的计算机视觉技术(表型组学)和强大的人工智能系统来推断化学领域的候选治疗药物。
ZhongAn Online (6060 HK)
+16%ZhongAn Online (6060 HK) rallied 16% on Thursday after disclosing gross written premium data that indicated a 45% year over year increase. ZhongAn Online is an internet-based insurance underwriter and distributor in China. Its core insurance products include health, auto, digital lifestyle including ecommerce returns, and consumer finance.

注: 众安在线(6060 HK)周四上涨16%,此前披露的总承保保费数据显示同比增长45%。众安在线是中国一家基于互联网的保险承保人和分销商。其核心保险产品包括健康、汽车、数字生活方式(包括电商退货)和消费金融。

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/ark-%e6%af%8f%e5%91%a8%e8%82%a1%e8%af%84-7-17-2021/

发表评论

您的电子邮箱地址不会被公开。 必填项已用*标注